Upload
jana-encabo
View
7
Download
1
Embed Size (px)
DESCRIPTION
HETAR activityBreast cancer on the Philippines
Citation preview
5/19/2018 Hetar Finals Activity
1/7
Breast Cancer 101: Ear ly detection i s best, says PCS
October, the Breast Cancer Awareness Month
With breast cancer being the no. 1 among all other cancer types in the country, there is an urgent need to inform and educate Filip
women on the advocacy for Breast Cancer is curable if detected early and treated properly.
Here are some more helpful information on breast cancer.
What is breast cancer?
Breast cancer is a type of cancer (or tumor) found in the tissues of the breast. There are two primary kinds of breast cancer: Du
Carcinoma (ductal tubes that channel milk to the nipple) and Lobular Carcinoma (from the mammary lobes).
How common is breast cancer in the Philippines?
According to the Philippine Cancer Facts and Estimates (PCFE) published by the Philippine Cancer Society, breast cancer ranks n
amongst all cancers in the country. What is unfortunate is that most Filipino women still lack information on breast cancer. So
believe that very few survive from the disease. The perceived cost of medical treatment prevent them from seeking help not know
that costs are manageable when the disease is detected early. Breast cancer in men is a rare occurrence though it can happen.
How will I know if I have breast cancer?
There are almost no symptoms in early breast cancer. This is why it is very important for early detection through regular breast
examination which should be done once a month. While the tumor is growing, one may have:
Growing lump, not regular in shape and painless
Change in the size, shape or sensitivity of the breast or nipple
Discharge on the nipple
If the cancer is advanced, symptoms may be:
Pain in any part of the bone
Pain on the breast
Swelling on the arm near the breast that has cancer
Sudden loss of weight
What is the cause of breast cancer?
There are no definite studies yet to pinpoint the cause of breast cancer. There are only studies to show the risk factors or those pron
for breast cancer. These risk factors can be divided into those that can be controlled and those that cannot be controlled.
The risk factors that we cannot have any control are: Gender. The disease afflicts 100x more women than men.
Age. Older women are at more risk for breast cancer.
Women with cancer on one breast that has been treated may replicate in the other breast. This is called recurrence.
The presence of breast cancer in a family member like the mother, sister, aunt or grandmother may increase risk. Early menstruation or late menopause.
Risk factors that we may have control (or lifestyle choices) are: Not having children or childbirth for women over 30 years old.
Use of Hormonal Replacement Therapy (HRT) after menopause.
Cigarette smoking or excessive alcohol intake.
Lack of physical activity or exercise which results in being obese or overweight.
5/19/2018 Hetar Finals Activity
2/7
If early detection can save lives, how do we detect breast cancer at an early stage?
The Philippine Cancer Society recommends regular monthly Breast Self-Examination (BSE), an annual clinical breast exam
mammography. Talking with your doctor is very important for guidance in detection.
What about treatment? How does the government intervene with breast cancer prevention and treatment?
Traditional forms of breast cancer treatment are surgery, chemotherapy, radiotherapy and immunotherapy. Recommended
multidisciplinary and inter-disciplinary approach where a team of medical specialists agree on a specific protocol or treatment for eand every cancer patient. The PCS has a pioneering program called Patient Navigation (PNAP) that assists cancer patients with t
diagnostics, medical treatment and psycho-social needs. For breast cancer, the PNAP is in partnership with the Breast Can
Medicine Access Program (BCMAP) of the Department of Health which gives free chemotherapy drugs for qualified patie
diagnosed with Breast Cancer Stage 3 B or earlier. Aside from this, the PCS has continuing free lectures in barangays, schools
workplaces to disseminate important information on breast cancer. The PCS also runs a free Consultation and Referral Clinic ev
Monday and Wednesday mornings. It maintains a directory of support groups, and networks with institutions, facilities and individu
who work on Breast Cancer care.
PCS gives demo on BSE at Avon Walk and Run
To highlight the importance of Breast Self-Examination (BSE) as an early detection approach to breast cancer for Filipino wom
PCS executive director Dr. Rachael Marie Rosario (center) assisted by GMA stars Lyn Ching and Solenn Heusaff, demonstrates
proper way to do BSE to participants at Avons Annual Walk and Run at the SM Mall of Asia recently (October 12, 2014). Hundof Filipino women learned firsthand the benefits of doing BSE and when to do it, as explained by Dr. Rosario. Other early detect
methods are clinical breast exam and mammography, Dr. Rosario added. PCS Trustee Dr. Angela Crisostomo and Dr. Rosario led
PCS staff during the 5km walk around the MOA grounds.
The PCS Cancer Prevention Guidelines are in 3 categories namely the primary, secondary and tertiary cancer prevention or clin
treatment guideline. Primary prevention of cancer is the prevention of cancer in an individual who does not have the dise
Secondary prevention of cancer is the early detection of cancer in an individual who has the disease but is asymptomatic for it; dis
is at the pre-clinical stage. Screening is the presumptive identification of unrecognized disease or defects by means of te
examinations, or other procedures that can be applied rapidly among asymptomatic target population on a large scale. Tertiary can
prevention or better known as clinical treatment is the treatment of symptomatic clinical cancer to prevent disease progression
complication/s. Among the three categories, breast cancer is categorized as secondary cancer prevention thats why if breast ca
can be treated successfully and if detected early, it has one of the highest survival rates among other cancers.
The following are risk factors for breast cancer:
1. Being female and older age. The risk of breast cancer in a 70 year old woman is about 10 times that of a 30 year old wom
Over her lifetime, a woman's risk of developing breast cancer is about one hundred times a man's risk.
2. A personal or family history of breast cancer or benign (non-cancer) breast diseaseeven your dads
Women with any of the following have an increased risk of breast cancer:
Apersonal history of breast cancer,ductal carcinoma in situ (DCIS) orlobular carcinoma in situ (LCIS).
A personal history ofbenign (non-cancer) breast disease.
Afamily history of breast cancer in afirst-degree relative (mother, sister, or daughter).
3. Inherited gene changes. Women who haveinherited certain changes in theBRCA1andBRCA2genes have a higher risk of br
cancer,ovarian cancer and maybecolon cancer.The risk of breast cancer caused by inherited gene changes depends on the t
of genemutation,family history ofcancer,and other factors. Men who have inherited certain changes in the BRCA2 gene havhigher risk of breast,prostate,andpancreatic cancers,andlymphoma.
4. Dense breasts. The level of risk depends on how dense the breast tissue is. Women with very dense breasts have a higher risk
breast cancer than women with low breast density. Increased breast density is often an inherited trait, but it may also occu
women who have not had children, have a firstpregnancy late in life, takepostmenopausal hormones,or drinkalcohol.
5. Estrogen made in the body. Estrogen is ahormone made by the body. It helps the body develop and maintain female
characteristics. Being exposed to estrogen over a long time may increase the risk of breast cancer. Estrogen levels are high
during the years a woman ismenstruating.A woman's exposure to estrogen is increased in the following ways:
Early menstruation: Beginning to havemenstrual periods at age 11 or younger increases the number of years the breast tissue
exposed to estrogen.
http://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=642021&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=45674&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=46315&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=45614&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=302456&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=460150&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=45098&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=46047&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=46047&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=46047&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=46742&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=46742&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=45693&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=445074&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=44237&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=46063&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=302456&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=45333&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=445079&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=44521&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=45368&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=666677&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=304725&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=463134&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=46076&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=45713&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=46297&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=45784&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=45784&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=46297&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=45713&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=46076&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=463134&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=304725&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=666677&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=45368&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=44521&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=445079&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=45333&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=302456&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=46063&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=44237&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=445074&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=45693&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=46742&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=46047&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=45098&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=460150&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=302456&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=45614&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=46315&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=45674&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=642021&version=Patient&language=English5/19/2018 Hetar Finals Activity
3/7
Latemenopause: The more years a woman menstruates, the longer her breast tissue is exposed to estrogen.
Late pregnancy or never being pregnant: Because estrogen levels are lower during pregnancy, breast tissue is exposed to mo
estrogen in women who become pregnant for the first time after age 35 or who never become pregnant.
6. Combination hormone replacement therapy/Hormone therapy. Hormones, such as estrogen andprogesterone,can be m
into a pill form in a laboratory. Estrogen,progestin,or both may be given to replace the estrogen no longer made by the ovarie
postmenopausal women or women who have had their ovaries removed. This is calledhormone replacement therapy (HRT
hormone therapy (HT). Combination HRT/HT is estrogen combined with progestin. This type of HRT/HT increases the risk
breast cancer. Studies show that when women stop taking estrogen combined with progestin, the risk of breast cancer decrease
7.
Exposure to radiation.Radiation therapy to the chest for the treatment of cancer increases the risk of breast cancer, starting
years after treatment. The risk of breast cancer depends on thedose ofradiation and the age at which it is given. The ris
highest if radiation treatment was used duringpuberty,when breasts are forming. However, radiation therapy to treat cance
one breast does not appear to increase the risk of cancer in the other breast.
For women who have inherited changes in theBRCA1andBRCA2genes, exposure to radiation, such as that fromches
rays,may further increase the risk of breast cancer, especially in women who were x-rayedbefore 20 years of age.
8.
Obesity. Obesity increases the risk of breast cancer, especially in postmenopausal women who have not used horm
replacement therapy.
9.
Alcohol. Drinkingalcohol increases the risk of breast cancer. The level of risk rises as the amount of alcohol consumed rises.
The following are protectivefactors for breast cancer:
1.
Less exposure to estrogen. Decreasing the length of time a woman's breast tissue is exposed to estrogen may help preventbrcancer. Exposure to estrogen is reduced in the following ways:
Early pregnancy: Estrogen levels are lower during pregnancy. Women who have a full-term pregnancy before age 20 have a low
risk of breast cancer than women who have not had children or who give birth to their first child after age 35.
Breast-feeding: Estrogen levels may remain lower while a woman is breast-feeding. Women who breastfed have a lower risk
breast cancer than women who have had children but did not breastfeed.
Ovarian ablation: The ovaries make estrogen. The amount of estrogen made by the body can be greatly reduced by removing one
both ovaries. Also,drugs may be taken to lower the amount of estrogen made by the ovaries.
Late menstruation: Beginning to have menstrual periods at age 14 or older decreases the number of years the breast tissue
exposed to estrogen.
Early menopause: The fewer years a woman menstruates, the shorter the time her breast tissue is exposed to estrogen.
2. Exercise. Women who exercise four or more hours a week have a lower risk of breast cancer. The effect of exercise on br
cancer risk may be greatest inpremenopausal women who have normal or low body weight.
3. Estrogen-only hormone therapy after hysterectomy. Hormone therapy with estrogen only may be given to women who h
had ahysterectomy.In these women, estrogen-only therapy after menopause may decrease the risk of breast cancer. There is
increased risk ofstroke andheart andblood vessel disease in postmenopausal women who take estrogen after a hysterectomy.
4.
Selective estrogen receptor modulators. Tamoxifen andraloxifenebelong to the family of drugs calledselective estro
receptor modulators(SERMs). SERMs act like estrogen on some tissues in the body, but block the effect of estrogen on ot
tissues.
Treatment with Tamoxifen or Raloxifene lowers the risk of breast cancer in postmenopausal women. Tamoxifen also lowers the
of breast cancer in high-risk premenopausal women. With either drug, the reduced risk lasts for several years after treatmen
stopped. Lower rates of broken bones have been noted in patients taking Raloxifene. Taking Tamoxifen increases the risk of
flashes,endometrial cancer, stroke,cataracts, andblood clots(especially in thelungs and legs). The risk of having these probl
increases with age. Women younger than 50 years who have a high risk of breast cancer may benefit the most from taking Tamoxi
The risk of having these problems decreases after Tamoxifen is stopped. Talk with your doctor about the risks and benefits of tak
this drug. Taking Raloxifene increases the risk of blood clots in the lungs and legs, but does not appear to increase the risk
endometrial cancer. In postmenopausal women withosteoporosis (decreasedbone density), Raloxifene lowers the risk of breast can
for women who have a high or low risk of breast cancer. It is not known if Raloxifene would have the same effect in women who
not have osteoporosis. Talk with your doctor about the risks and benefits of taking this drug. Other SERMs are being studie
clinical trials.
http://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=46296&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=46296&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=45158&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=304743&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=46687&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=45269&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=46127&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=44971&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=44971&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=44664&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=45072&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=440113&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=304687&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=304687&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=45944&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=527371&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=463134&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=439419&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=45811&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=45811&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=348921&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=449953&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=449953&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=45268&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=45718&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=439425&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=748138&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=45020&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=45576&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=46046&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=44229&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=44229&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=256567&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=444987&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=440102&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=476017&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=270740&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=45371&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=407755&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=407755&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=45371&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=270740&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=476017&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=440102&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=444987&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=256567&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=44229&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=44229&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=46046&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=45576&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=45020&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=748138&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=439425&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=45718&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=45268&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=449953&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=348921&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=45811&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=439419&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=463134&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=527371&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=45944&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=304687&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=304687&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=440113&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=45072&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=44664&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=44971&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=46127&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=45269&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=46687&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=304743&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=45158&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=46296&version=Patient&language=English5/19/2018 Hetar Finals Activity
4/7
5.
Aromatase inhibitors and inactivators.Aromatase inhibitors (Anastrozole,Letrozole)and inactivators (Exemestane)lower
risk of a new breast cancer in women who have a history of breast cancer. Aromatase inhibitors also decrease the risk of br
cancer in women with the following conditions:
Postmenopausal women with a personal history of breast cancer.
Women with no personal history of breast cancer who are 60 years and older, have a history of ductal carcinoma
situ withmastectomy,or have a high risk of breast cancer based on theGail model tool (a tool used to estimate the risk of bre
cancer).
In women with an increased risk of breast cancer, taking aromatase inhibitors decreases the amount of estrogen made by the bo
Before menopause, estrogen is made by the ovaries and other tissues in a woman's body, including the brain, fat tissue, and skin. A
menopause, the ovaries stop making estrogen, but the other tissues do not. Aromatase inhibitors block the action of an enzyme ca
aromatase, which is used to make all of the body's estrogen. Aromatase inactivators stop the enzyme from working. Possible ha
from taking aromatase inhibitors include muscle andjointpain, osteoporosis, hot flashes, and feeling very tired.
6. Prophylactic mastectomy. Some women who have a high risk of breast cancer may choose to have a prophyla
mastectomy (the removal of both breasts when there are no signs of cancer). The risk of breast cancer is much lower in th
women and most feel lessanxious about their risk of breast cancer. However, it is very important to have a cancer risk assessm
andcounseling about the different ways to prevent breast cancer before making this decision.
7. Prophylactic oophorectomy. Premenopausal women who have a high risk of breast cancer due to certain changes in the BRC
and BRCA2 genes may choose to have aprophylactic oophorectomy (the removal of both ovaries when there are no sign
cancer). This decreases the amount of estrogen made by the body and lowers the risk of breast cancer. Prophylactic oophorecto
also lowers the risk of breast cancer in normal premenopausal women and in women with an increased risk of breast cancer du
radiation to the chest. However, it is very important to have a cancer risk assessment and counseling before making this decis
The sudden drop in estrogen levels may cause thesymptoms of menopause to begin. These include hot flashes, trouble sleep
anxiety, anddepression.Long-term effects include decreasedsex drive,vaginal dryness, and decreased bone density.
8.
Bisphosphonates. Bisphosphonates are drugs used to treat osteoporosis andhypercalcemia and to prevent bone fracture
cancer patients. When taken by mouth or byintravenous infusion for more than 1 year they may lower the risk of breast cancer
9.
There are studies that show that breastfeeding for more than one year lowers the risk for breast cancer.
It is not clear whether the following affect the risk of breast cancer:
1. Oral contraceptives. Takingoral contraceptives ("the pill") may slightly increase the risk of breast cancer in current users. T
risk decreases over time. Some oral contraceptives contain estrogen.
Progestin-only contraceptives that areinjected orimplanted do not appear to increase the risk of breast cancer.
2. Environment. Studies have not proven that being exposed to certain substances in the environment, such aschemicals,increases
risk of breast cancer.
The following do not affect the risk of breast cancer.
Having an abortion.
Makingdiet changes such as eating less fat or more fruits and vegetables.
Takingvitamins,includingfenretinide (a type ofvitamin A).
Cigarette smoking, both active and passive (inhalingsecondhand smoke).
Using underarm deodorant or antiperspirant. (Definitely a no!)
Takingstatins such as atorvastatin, simvastatin, etc. (cholesterol -lowering drugs).
http://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=44232&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=44232&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=45504&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=45421&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=45445&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=45674&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=45674&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=45777&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=256564&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=46081&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=458080&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=44227&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=44227&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=430405&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=450098&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=44932&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=45022&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=430479&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=651212&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=44308&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=44817&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=45363&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=520363&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=443306&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=44678&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=285636&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=643008&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=44660&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=44744&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=45233&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=45248&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=748148&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=538647&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=390255&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=407756&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=407756&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=390255&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=538647&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=748148&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=45248&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=45233&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=44744&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=44660&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=643008&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=285636&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=44678&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=443306&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=520363&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=45363&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=44817&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=44308&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=651212&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=430479&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=45022&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=44932&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=450098&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=430405&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=44227&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=44227&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=458080&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=46081&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=256564&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=45777&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=45674&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=45674&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=45445&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=45421&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=45504&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=44232&version=Patient&language=English5/19/2018 Hetar Finals Activity
5/7
Comment:
On this study, I learned about what breast cancer really is, how it occurs, what causes it, how to avoid it, its preven
measures and how to treat it.
Breast cancer is a type of cancer (or tumor) found in the tissues of the breast which has two primary kinds of breast can
the Ductal Carcinoma, the ductal tubes that channel milk to the nipple and Lobular Carcinoma which occurs in the mammary lobes
For the causes of breast cancer, I made an acronym TEWAG to be easy recalled or remembered where T stands for presence of breast cancer in a family member like the mother, sister, aunt or grandmother may increase risk; E is for E
menstruation or late menopause; W for Women with cancer on one breast that has been treated may replicate in the other breast. T
is called recurrence; A for age; and G for gender.
Preventive measures for breast cancer is mainly eating healthy foods, taking supplements and exercising. NEVER
INACTIVE. Always have time for a 30-minute exercise once a month to keep yourself healthy. If you are already a mother, breastf
often. Some studies show that breastfeeding lowers the risk of breast cancer. Always check yourself. Breast Self-Examination (B
every month and an annual clinical breast exam and mammography for symptoms of breast cancer. Talking with your doctor is v
important for guidance in detection. As the Philippine Cancer Society (PCS) says, early detection is the best cure.
For the treatment, traditional forms of breast cancer treatment are surgery, chemotherapy, radiotherapy and immunothera
Recommended is a multidisciplinary and inter-disciplinary approach where a team of medical specialists agree on a specific protor treatment for each and every cancer patient. As St. Benedict says, ora et labora or prayer and work. Everything can be poss
with prayers to God.
The information I found on the websites are really helpful for breast cancer awareness. They are well explained and can
understood by the norm. They are giving stress that not only women are susceptible with breast cancer but also to the men to elimin
the wrong notions of the Filipinos.
To summarize everything, I think our country really gives importance to cancer prevention and treatment especially to br
cancer maybe because it ranked number one among all the types of cancer in our country. I may say that the government and priv
sectors are really working hand in hand with each other in helping to disseminate the information about breast cancer. As of now, t
are providing lectures about breast cancer in the barangays, schools and workplaces. Furthermore, they also have programs such as
BSE at Avon Walk and Run which aims to collect money for funding the breast cancer treatment of our fellow Filipinos who are capable of paying for their breast cancer therapy, for information dissemination and breast cancer prevention. Informa
dissemination to all Filipinos will help lessen and eradicate the spreading of breast cancer!
5/19/2018 Hetar Finals Activity
6/7
References:
http://www.philcancer.org.ph/breast-cancer-101-early-detection-is-best-says-pcs/
http://www.philcancer.org.ph/pcs-gives-demo-on-bse-at-avon-walk-and-run/
http://www.philcancer.org.ph/learn-about-cancer/cancer-prevention-guidelines/
http://www.philcancer.org.ph/learn-about-cancer/stay-healthy/
http://www.cancer.gov/cancertopics/pdq/prevention/breast/Patient/page3
VISIT for more informations:
http://philcancerorgph.ipage.com/wp-content/uploads/2014/04/Healthy-Lifestyle-Leaflet.pdfsi
http://www.philcancer.org.ph/breast-cancer-101-early-detection-is-best-says-pcs/http://www.philcancer.org.ph/pcs-gives-demo-on-bse-at-avon-walk-and-run/http://www.philcancer.org.ph/learn-about-cancer/cancer-prevention-guidelines/http://www.philcancer.org.ph/learn-about-cancer/stay-healthy/http://www.cancer.gov/cancertopics/pdq/prevention/breast/Patient/page3http://philcancerorgph.ipage.com/wp-content/uploads/2014/04/Healthy-Lifestyle-Leaflet.pdfsihttp://philcancerorgph.ipage.com/wp-content/uploads/2014/04/Healthy-Lifestyle-Leaflet.pdfsihttp://www.cancer.gov/cancertopics/pdq/prevention/breast/Patient/page3http://www.philcancer.org.ph/learn-about-cancer/stay-healthy/http://www.philcancer.org.ph/learn-about-cancer/cancer-prevention-guidelines/http://www.philcancer.org.ph/pcs-gives-demo-on-bse-at-avon-walk-and-run/http://www.philcancer.org.ph/breast-cancer-101-early-detection-is-best-says-pcs/5/19/2018 Hetar Finals Activity
7/7
Health Economics with Taxation and
Land Reform
Submitted by:
Jana Tria Q. Encabo2E-Pharmacy
Submitted to:
Mr. Atanasio A. Abadingo